An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

Deraya University300 enrolled

Overview

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Drug Reaction Drug Hypersensitivity Drug Abuse Drug Interaction

Interventions

questionner

Eligibility

Sex: ALLMin age: 25 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * all health care providers are invited to share in the study * minimum experience required is one year in health carrier. * accept sharing in the study Exclusion Criteria: * health care providers who refuse to complete all data required in the survey. * fresh experience or participants who left health carrier

Outcomes

Primary Outcomes

reported adverse drug reactions

collect recent adverse drug reaction reports

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.